MedPath

Multivessel Disease Diagnosed at the Time of PPCI for STEMI: Complete Revascularization Versus Conservative Strategy.

Not Applicable
Completed
Conditions
Coronary Artery Stenosis
Interventions
Procedure: Percutaneous coronary intervention
Registration Number
NCT01332591
Lead Sponsor
St. Anne's University Hospital Brno, Czech Republic
Brief Summary

The aim of the study is to find the optimal management of patients with acute myocardial infarction with ST elevations treated by primary PCI who have at least one significant stenosis of non-culprit coronary artery. The primary endpoint of the study will be incidence of combined endpoint of all cause mortality, nonfatal myocardial infarction and stroke during the follow up of 24 months in group of patients treated with staged revascularization (PCI or CABG) in comparison with patients treated conservatively.

Detailed Description

Introduction:

Primary percutaneous coronary intervention (PPCI) of the occlussion or significant stenosis of infarct artery is a method of choice in treatment of acute myocardial infarction with ST segment elevation (STEMI). It is not clear, what is the optimal management of patients with acute myocardial infarction with ST elevations (STEMI) treated by primary percutaneous coronary intervention (PPCI) who have at least one significant stenosis of non-culprit coronary artery. Numerous cardiology centers perform staged PCI on significant stenoses involving the "non-infarct" coronary artery (arteries) 3-40 days after PPCI, but the benefit of this staged PCI for such patients has not yet been clearly demonstrated.

Aim of study:

The aim is to find the optimal management of patients with acute myocardial infarction with ST elevations (STEMI) treated by PPCI who have at least one significant stenosis of non-culprit coronary artery. The primary endpoint of the study will be incidence of combined endpoint of all cause mortality, nonfatal myocardial infarction and stroke during the follow up of 24 months in group of patients treated with staged revascularization (PCI or CABG) in comparison with patients treated conservatively.

Hypothesis:

Our hypothesis is that complete staged revascularization of significant stenoses of the coronary arteries will improve the long-term prognosis in patients after PPCI as compared to conservative management.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
213
Inclusion Criteria
  • Patient with acute myocardial infarction with ST segment elevation (STEMI)
  • Angiographically successful primary PCI of infarct-related stenosis (TIMI flow grades II-III)
  • One or more other stenoses (≥70%) of "non-infarct" coronary artery (arteries) found by coronary angiography, (diameter of artery ≥ 2,5mm)
  • Enrollment ≥48 hours following onset of symptoms
Exclusion Criteria
  • Stenosis of the left main of left coronary artery ≥ 50%
  • Hemodynamically significant valvular disease
  • Patients in cardiogenic shock during STEMI
  • Hemodynamic instability
  • Angina pectoris > grade 2 CCS lasting 1 month prior to STEMI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Complete revascularizationPercutaneous coronary interventionPercutaneous coronary intervention of "non-infarct" coronary arteries
Primary Outcome Measures
NameTimeMethod
composite endpoint of death, nonfatal acute myocardial infarction and stroke2 years
Secondary Outcome Measures
NameTimeMethod
changes of left ventricular ejection fraction2 years
target lesion revascularization2 years

non infarct artery

recurrent myocardial infarction2 years
hospitalization for heart failure2 years
hospitalization for unstable angina pectoris2 years
target vessel revascularization2 years

non infarct artery

target vessel failure2 years

progression of studied stenosis of non-culprit artery

cardiovascular death2 years
stroke2 years
outcomes of questionnaire regarding angina pectoris2 years

Trial Locations

Locations (1)

Department of Cardioangiology, St. Anne University Hospital

🇨🇿

Brno, Czech Republic

© Copyright 2025. All Rights Reserved by MedPath